Cargando…

Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses

Detalles Bibliográficos
Autores principales:	Mdluli, Thembi, Jian, Ningbo, Slike, Bonnie, Paquin-Proulx, Dominic, Donofrio, Gina, Alrubayyi, Aljawharah, Gift, Syna, Grande, Rebecca, Bryson, Mary, Lee, Anna, Dussupt, Vincent, Mendez-Rivera, Letzibeth, Sanders-Buell, Eric, Chenine, Agnès-Laurence, Tran, Ursula, Li, Yifan, Brown, Eric, Edlefsen, Paul T., O’Connell, Robert, Gilbert, Peter, Nitayaphan, Sorachai, Pitisuttihum, Punnee, Rerks-Ngarm, Supachai, Robb, Merlin L., Gramzinski, Robert, Alter, Galit, Tovanabutra, Sodsai, Georgiev, Ivelin S., Ackerman, Margaret E., Polonis, Victoria R., Vasan, Sandhya, Michael, Nelson L., Kim, Jerome H., Eller, Michael A., Krebs, Shelly J., Rolland, Morgane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924741/ https://www.ncbi.nlm.nih.gov/pubmed/33651828 http://dx.doi.org/10.1371/journal.ppat.1009386

Ejemplares similares

RV144 HIV-1 vaccination impacts post-infection antibody responses
por: Mdluli, Thembi, et al.
Publicado: (2020)

RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
por: Lewitus, Eric, et al.
Publicado: (2021)

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor
por: Peachman, Kristina K., et al.
Publicado: (2015)

CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants
por: Dommaraju, Kalpana, et al.
Publicado: (2014)

Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth
por: Li, Yifan, et al.
Publicado: (2021)

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
por: Zolla-Pazner, Susan, et al.
Publicado: (2014)

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
por: Fischinger, Stephanie, et al.
Publicado: (2020)

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders
por: Janes, Holly, et al.
Publicado: (2015)

Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission
por: Barrows, Brittani M., et al.
Publicado: (2022)

Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines
por: Matyas, Gary R., et al.
Publicado: (2010)

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
por: Chenine, A, et al.
Publicado: (2009)

Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand
por: Pitisuttithum, Punnee, et al.
Publicado: (2015)

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
por: Montefiori, David C., et al.
Publicado: (2012)

Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
por: Auclair, Sarah, et al.
Publicado: (2018)

Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
por: Edlefsen, Paul T., et al.
Publicado: (2015)

An HIV Vaccine for South-East Asia—Opportunities and Challenges
por: Pitisuttithum, Punnee, et al.
Publicado: (2013)

A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection
por: Wang, Yufei, et al.
Publicado: (2017)

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
por: Kuriakose Gift, Syna, et al.
Publicado: (2023)

A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination
por: Lemke, Melissa M., et al.
Publicado: (2021)

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees
por: Choi, Ickwon, et al.
Publicado: (2015)

A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination
por: Lemke, Melissa M., et al.
Publicado: (2022)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E
por: Ratto-Kim, Silvia, et al.
Publicado: (2015)

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
por: Shangguan, Shida, et al.
Publicado: (2021)

Aggregate complexes of HIV-1 induced by multimeric antibodies
por: Stieh, Daniel J, et al.
Publicado: (2014)

Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee()
por: Nicely, Nathan I., et al.
Publicado: (2015)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand
por: Rolland, Morgane, et al.
Publicado: (2020)

Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine
por: Li, Yifan, et al.
Publicado: (2023)

Intestinal attenuation of COVID-19 inflammation
por: Alrubayyi, Aljawharah
Publicado: (2020)

NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020)

Publisher Correction: NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020)

Coordinated and sustained immune memory responses after mild COVID-19
por: Alrubayyi, Aljawharah
Publicado: (2020)

B cell persistence and evolution to SARS-CoV-2
por: Alrubayyi, Aljawharah
Publicado: (2020)

Factors influencing estimates of HIV-1 infection timing using BEAST
por: Dearlove, Bethany, et al.
Publicado: (2021)

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2
por: Rolland, Morgane, et al.
Publicado: (2012)

HIV-1 infections with multiple founders associate with the development of neutralization breadth
por: Lewitus, Eric, et al.
Publicado: (2022)

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
por: Perez, Lautaro G., et al.
Publicado: (2017)

Seeing SARS-CoV-2 variants through the eyes of T cells
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone
por: Chenine, Agnès-Laurence, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vplpta6vq5lniuhnqcasncplpl